Cannabis

Canopy Growth Corp. posted a larger loss in its latest quarter compared with a year ago as its revenue declined.

Tilray Brands Inc. is nearing an agreement to acquire some of the drinks brands of brewer Molson Coors Beverage Co., people familiar with the matter said.

The Philippines is trying again to pass a bill allowing the use of cannabis for medical purposes after past failed attempts, with the House of Representatives approving a measure on Tuesday.

Bruce Campbell, president and portfolio manager at StoneCastle Investment Management, joins BNN Bloomberg to discuss the cannabis sector outlook amid U.S. regul

Thailand’s move to shelve a plan to re-criminalize cannabis in favor of tightening regulations is a “people’s victory,” according to the leader of a party that’s widely credited for spearheading a landmark decriminalization two years ago.

Frederico Gomes, director of institutional research in life sciences at ATB Capital Markets, joins BNN Bloomberg to share his top picks in cannabis stocks.

Tilray Brands Inc. says it's launching a new brand of premium non-alcoholic beverages.

Roundhill Investments is completely waiving the fee for its US$5.6 million cannabis fund as U.S. regulators move to reclassify marijuana as a less dangerous substance.

Canadian cannabis stocks are rallying after U.S. President Joe Biden announced the country had taken a "major step" toward reclassifying pot as a less dangerous drug.

Shares of cannabis company Tilray Brands Inc. were down more than 20 per cent after it reported its latest quarterly results and cut its full-year guidance.

A chain of cannabis stores in Ontario has been fined $200,000 after it allegedly asked cannabis producers for inducements in exchange for preferential treatment in its stores.

As Germany moves toward cannabis legalization, Canopy Growth Corp.’s top executive says new legislation could drastically expand the market.

Minnesota probably won't meet its goal of launching full-scale retail marijuana sales in the first quarter of 2025 because of the time it will take to draft regulations and issue licenses, the state’s top cannabis regulator acknowledged Thursday.

Aurora Cannabis Inc. bolstered its international presence Thursday with a deal to buy the 90 per cent of Australian medical cannabis company MedReleaf Australia it didn't already own.

Aurora Cannabis Inc. has announced a plan to consolidate its shares on a one-for-10 basis.